WakeMed Health & Hospitals
Raleigh, North Carolina, 27610, United States
Location status: Recruiting
Recruiting
NCT Number: NCT06754514
Organ Retractor Device Study
This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- undergoing minimally invasive primary bariatric surgery
Exclusion criteria
- known liver disease
Treatment and study plan
liver retraction
DeviceA different way to lift the liver during bariatric surgery
Primary outcomes
-
Ease of use and Feasibility
Time frame: During surgery
After surgery, surgeons will be asked a series of questions and asked to rank the ease of use on a scale of 1-10
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Boehringer Labs LLC
Industry
Registry information
Official study title
Boehringer Laboratories Organ Retractor Device Study
Important dates
- Study start
- 2024
- Primary completion
- 2024
- Study completion
- 2025
- First posted
- Jan 1, 2025
- Registry last updated
- Jan 1, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.